NCT07299708

Brief Summary

This prospective observational study evaluates whether maternal sleep quality, anxiety levels, and nighttime digital behavior are associated with labor progression among term primiparous women. Sleep quality and anxiety are assessed before the onset of labor during routine antenatal visits using validated instruments, including the Pittsburgh Sleep Quality Index (PSQI) and the Beck Anxiety Inventory (BAI). Nighttime digital behavior characteristics, such as screen exposure and smartphone use prior to sleep, are recorded through standardized antenatal interviews. Labor outcomes, including the duration of the latent, active, and second stages of labor, requirement for oxytocin augmentation, use of analgesia, and mode of delivery, are prospectively documented from hospital admission until birth. By examining behavioral and psychological factors prior to labor onset, the study aims to determine whether poor sleep quality, increased anxiety, or irregular nighttime digital activity are associated with prolonged labor phases or greater need for obstetric interventions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
127

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 10, 2025

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

November 23, 2025

Completed
2 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 25, 2025

Completed
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2025

Completed
23 days until next milestone

First Posted

Study publicly available on registry

December 23, 2025

Completed
Last Updated

December 23, 2025

Status Verified

December 1, 2025

Enrollment Period

4 months

First QC Date

November 23, 2025

Last Update Submit

December 22, 2025

Conditions

Keywords

Sleep QualityAnxietyDigital BehaviorPrimiparous WomenChildbirthOxytocin Augmentation

Outcome Measures

Primary Outcomes (1)

  • Duration of Active Labor

    Time in minutes from the onset of active labor (defined as cervical dilatation of ≥4 cm with regular contractions) to full cervical dilatation (10 cm). Data will be obtained prospectively from electronic delivery records.

    From onset of active labor (≥4 cm) until full cervical dilatation (10 cm), typically within 2 to 12 hours.

Secondary Outcomes (8)

  • Duration of Latent Phase of Labor

    From onset of regular contractions until onset of active labor (≥4 cm), typically lasting up to 20 hours.

  • Duration of Second Stage of Labor

    From full dilatation (10 cm) until birth, typically lasting up to 3 hours.

  • Oxytocin Augmentation Requirement

    From admission in active labor (≥4 cm) until delivery, typically within 2 to 12 hours.

  • Mode of Delivery

    Assessed at delivery.

  • Use of Epidural Analgesia

    From onset of active labor (≥4 cm) until delivery, typically within 2 to 12 hours.

  • +3 more secondary outcomes

Study Arms (1)

Primiparous Cohort

Term primiparous women assessed for sleep quality, anxiety, digital behavior, and followed through spontaneous labor.

Other: No Intervention: Observational Cohort

Interventions

Observational study with no assigned treatment or intervention.

Primiparous Cohort

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsOnly self-identified women who are biologically female and pregnant are eligible to participate in this study.
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

This study population consists of term primiparous pregnant women who attended routine antenatal follow-up at Izmir Tepecik Training and Research Hospital and subsequently experienced spontaneous onset of labor. All participants were healthy, low-risk obstetric patients with singleton, cephalic presentations and no medical or obstetric complications.

You may qualify if:

  • Pregnant women at ≥ 37 weeks of gestation
  • Completion of PSQI (sleep quality) and BAI (anxiety) assessments during antenatal clinic visit
  • Singleton pregnancy
  • Cephalic presentation
  • Age 18 to 50 years
  • Planning to deliver at the study hospital
  • Able to provide informed consent

You may not qualify if:

  • Multiple pregnancy
  • Non-cephalic presentation
  • Delivery occurring at another hospital or birth center
  • Elective planned cesarean delivery
  • Major fetal anomaly
  • Placenta previa or placenta accreta spectrum
  • Preeclampsia, eclampsia, HELLP syndrome
  • Gestational diabetes requiring insulin
  • Chronic medical disorders affecting labor physiology
  • Use of sedative, hypnotic, or psychotropic medications
  • Inability to complete questionnaires

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tepecik Training and Research Hospital

Izmir, 35020, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Sleep Initiation and Maintenance DisordersAnxiety Disorders

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Obstetrics and Gynecology Specialist, Principal Investigator

Study Record Dates

First Submitted

November 23, 2025

First Posted

December 23, 2025

Study Start

August 10, 2025

Primary Completion

November 25, 2025

Study Completion

November 30, 2025

Last Updated

December 23, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared. The dataset contains sensitive clinical information from pregnant women and cannot be made publicly available due to institutional and national data protection regulations. Summary results will be published in peer-reviewed journals, but no individual-level data will be released.

Locations